Good Agricultural and Collection Practices (GACP) certification is the first quality gate any serious cannabis importer should impose on a Canadian supplier. Introduced by the European Medicines Agency as a companion to EU-GMP, GACP governs the cultivation, harvest, and primary processing of medicinal cannabis at the farm level. Without it, flower destined for regulated markets in Germany, Australia, or Israel cannot legally enter a compliant manufacturing chain. If you are sourcing dried cannabis from a Canadian Licensed Producer for medical distribution, GACP is not a bonus certification. It is a baseline requirement.
What GACP Actually Covers
GACP applies to the agricultural stage of cannabis production, from genetics selection and growing environment through harvest and initial drying. The standard is grounded in the EMA Guidelines on Good Agricultural and Collection Practice for starting materials of herbal origin, adapted for cannabis by major importing regulators including Germany's Bundesopiumstelle and Australia's Office of Drug Control.
For a Canadian Licensed Producer to achieve GACP certification, the facility must demonstrate: documented standard operating procedures for cultivation, harvesting, and post-harvest handling; contamination controls covering pesticides, heavy metals, microbials, and foreign material; traceability systems linking each batch to its source genetics, growing conditions, and testing records; and personnel training records confirming staff understand and follow the SOPs consistently.
Critically, GACP covers the upstream process that determines product quality before a product ever reaches a GMP manufacturer. A finished pharmaceutical product is only as clean as its starting material. For B2B buyers building supply chains into Germany or Australia, GACP at the cultivation facility is the upstream quality assurance that a Certificate of Analysis (COA) alone cannot fully confirm.
GACP vs. EU-GMP: Why Both Matter
A common procurement error is treating GACP and EU-GMP as interchangeable. They are not. GACP governs growing. EU-GMP governs manufacturing. A Canadian LP that holds GACP certification can supply dried flower as a starting material to an EU-GMP-certified facility, where the flower is tested, packaged, and released as a finished medical product. A Canadian LP that holds EU-GMP certification can perform both functions internally. Both pathways are legitimate, but understanding which your supplier holds, and what the downstream implications are, determines whether your supply chain complies with the regulatory requirements in your market.
Under the Cannabis Regulations (SOR/2018-144), Canadian LPs must hold an import or export permit issued by Health Canada for each international shipment. GACP and EU-GMP certifications are the quality credentials that foreign regulators accept as proof the product was produced under a rigorous, documented system. Without them, a narcotic import permit in Germany or Australia will not be granted, regardless of COA scores.
A Practical Checklist for Evaluating a Canadian LP's GACP Status
Before entering a supply agreement with a Canadian Licensed Producer for regulated international distribution, a B2B buyer should verify the following:
- Certification scope: Which facility (or facilities) hold GACP certification, and does the scope cover the specific product types you intend to purchase? A facility can hold GACP for one site and not another.
- Certifying body: GACP certifications issued by accredited third-party auditors (Control Union, Bureau Veritas, TÜV Rheinland) carry greater weight with importing regulators than self-assessments. Request the audit report and certificate number.
- Certification date and renewal schedule: GACP audits are not one-time events. Ask when the most recent audit was conducted and when the next recertification is due. A certificate that expired 18 months ago provides limited assurance.
- Scope alignment with target market: German BfArM requirements, Australian TGO 93 requirements, and Israeli IMC-GMP standards each have nuances. Confirm the LP's certification was audited against the guidelines applicable to your target market.
- Traceability documentation: GACP compliance is largely a documentation exercise. Request a sample batch record to verify that seed-to-harvest traceability is real: batch ID, genetics source, grow conditions, harvest date, testing lab (ISO/IEC 17025-accredited), and COA linkage.
- Integration with downstream GMP: If the LP does not hold EU-GMP itself, identify which EU-GMP-certified manufacturer will perform finished product release. The LP-to-manufacturer chain must be documented and approved by the importing regulator.
Why Indoor Cultivation and Hand-Trimming Elevate GACP Compliance
GACP certification confirms a facility meets minimum standards. What it does not reveal is where within those standards a producer operates. A procurement manager evaluating two GACP-certified facilities for a German medical channel is really asking: which one produces consistently high-quality flower with minimal post-harvest variability?
Indoor cultivation provides tighter environmental controls than greenhouse or outdoor production, reducing the risk of contaminant exposure from outside air, soil, or weather-driven moisture variance. Hand-trimming preserves trichome density and reduces mechanical damage that can lower tested THC values and increase microbial risk from bruised plant tissue. Both factors support GACP compliance and, more practically, predictable batch-to-batch COA results.
For the Montréal facility at AlphaLeaf, the combination of indoor cultivation, hand-trimmed processing, ISO-certified third-party testing, and full batch traceability reflects these priorities directly. Each batch is linked end-to-end from genetic selection through to the export permit application submitted to Health Canada.
GACP and the Cannabis Act: The Canadian Regulatory Connection
Under the Cannabis Act and the Cannabis Regulations, Health Canada's Good Production Practices (GPP) framework governs how Canadian Licensed Producers must operate. Canadian GPP is not identical to GACP, but a producer operating to GPP has completed much of the underlying documentation and quality system work that GACP auditors will expect to see. Canadian LPs with a long operating history under GPP are often better positioned for GACP certification than newer entrants, because the systems are already embedded in day-to-day operations.
When a Canadian LP applies to Health Canada for an export permit under the Cannabis Regulations, the application must specify the importing country and its applicable requirements. For Germany, the Bundesopiumstelle requires evidence that the product originates from a facility operating under GACP or equivalent. For Australia, the ODC requires alignment with TGO 93 and GACP-equivalent documentation. The Canadian export permit process is the point at which GACP status becomes directly material to whether a shipment can legally proceed. Learn more about AlphaLeaf's export authorisation at alphaleaf.ca/#international.
Frequently Asked Questions
What is the difference between GACP and Good Manufacturing Practice (GMP) in cannabis?
GACP applies to the cultivation, harvest, and primary processing of cannabis at the agricultural stage. GMP, specifically EU-GMP in international medical cannabis trade, applies to the manufacturing, packaging, testing, and release of finished medicinal products. Both certifications address different parts of the supply chain. International importing regulators typically require both to be represented, either in a single LP that holds both, or through a GACP-certified cultivator supplying to a GMP-certified manufacturer.
Does a Canadian Licensed Producer need GACP certification to export cannabis to Germany?
Germany's Bundesopiumstelle requires that medicinal cannabis imported into the country originates from a facility producing under GACP or equivalent documentation standards. In practice, Canadian LPs pursuing the German medical channel either hold formal GACP certification or demonstrate GACP-equivalent processes through Health Canada's GPP framework and supporting documentation. Formal GACP certification from an accredited third-party auditor is the clearest way to satisfy BfArM requirements without ambiguity during the import permit review.
How does ISO/IEC 17025 accreditation relate to GACP compliance?
ISO/IEC 17025 accreditation applies to the testing laboratories that analyse cannabis samples for potency, terpene profiles, microbial contamination, residual solvents, and heavy metals. GACP requires that batch testing be conducted by a qualified laboratory. ISO/IEC 17025-accredited labs provide the highest level of documented testing credibility, and many importing regulators expect COAs to be issued by labs holding this accreditation. A GACP-certified producer whose testing partner is ISO/IEC 17025-accredited presents the most complete quality documentation chain available in the Canadian LP market.
Can GACP certification alone be used as a supplier qualification criterion?
GACP certification is a necessary but not sufficient qualifier. It confirms the production process meets documented standards; it does not guarantee product potency, consistency, or export track record. A full supplier qualification process should also include review of export permit history, sample batch COAs across multiple lots, reference checks with existing international supply partners, and an assessment of the LP's operational capacity to meet volume requirements reliably over a multi-year supply agreement. Review AlphaLeaf's quality certifications as a reference point for what a thorough documentation package looks like.
Verify Before You Commit
The growing field of GACP-certified Canadian LPs means buyers now have more quality-validated supply options than at any point in the industry's export history. That is good news. It also raises the bar for what buyers should be demanding during supplier qualification, because the difference between a GACP certificate on paper and a genuinely compliant, traceable production system is significant. Ask for the audit report. Review the batch records. Confirm the downstream GMP partner. The documentation requirements exist precisely because the stakes, for patients and for regulatory compliance, are high.
To discuss AlphaLeaf's GACP documentation, batch records, or export permit history for your market, contact the international team directly.
